25 XP   0   0   10

Renhe Pharmacy Co Ltd
Buy, Hold or Sell?

Let's analyse Renhe Pharmacy Co Ltd together

PenkeI guess you are interested in Renhe Pharmacy Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Renhe Pharmacy Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Renhe Pharmacy Co Ltd

I send you an email if I find something interesting about Renhe Pharmacy Co Ltd.

Quick analysis of Renhe Pharmacy Co Ltd (30 sec.)










What can you expect buying and holding a share of Renhe Pharmacy Co Ltd? (30 sec.)

How much money do you get?

How much money do you get?
¥0.06
When do you have the money?
1 year
How often do you get paid?
75.0%

What is your share worth?

Current worth
¥4.86
Expected worth in 1 year
¥5.17
How sure are you?
95.0%

+ What do you gain per year?

Total Gains per Share
¥0.77
Return On Investment
11.8%

For what price can you sell your share?

Current Price per Share
¥6.57
Expected price per share
¥5.1649731397459 - ¥6.86
How sure are you?
50%

1. Valuation of Renhe Pharmacy Co Ltd (5 min.)




Live pricePrice per Share (EOD)

¥6.57

Intrinsic Value Per Share

¥3.63 - ¥5.44

Total Value Per Share

¥8.49 - ¥10.29

2. Growth of Renhe Pharmacy Co Ltd (5 min.)




Is Renhe Pharmacy Co Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$941.3m$850.2m$64.4m7.0%

How much money is Renhe Pharmacy Co Ltd making?

Current yearPrevious yearGrowGrow %
Making money$22.7m$20.6m$2.1m9.4%
Net Profit Margin12.9%11.6%--

How much money comes from the company's main activities?

3. Financial Health of Renhe Pharmacy Co Ltd (5 min.)




What can you expect buying and holding a share of Renhe Pharmacy Co Ltd? (5 min.)

Welcome investor! Renhe Pharmacy Co Ltd's management wants to use your money to grow the business. In return you get a share of Renhe Pharmacy Co Ltd.

What can you expect buying and holding a share of Renhe Pharmacy Co Ltd?

First you should know what it really means to hold a share of Renhe Pharmacy Co Ltd. And how you can make/lose money.

Speculation

The Price per Share of Renhe Pharmacy Co Ltd is ¥6.57. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Renhe Pharmacy Co Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Renhe Pharmacy Co Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥4.86. Based on the TTM, the Book Value Change Per Share is ¥0.08 per quarter. Based on the YOY, the Book Value Change Per Share is ¥0.14 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.11 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Renhe Pharmacy Co Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.020.3%0.020.2%0.010.2%0.010.2%0.010.2%
Usd Book Value Change Per Share0.020.3%0.010.2%0.020.3%0.010.2%0.010.2%
Usd Dividend Per Share0.000.0%0.020.2%0.000.1%0.010.2%0.010.1%
Usd Total Gains Per Share0.020.3%0.030.4%0.020.3%0.030.4%0.020.3%
Usd Price Per Share0.99-0.89-1.01-0.95-0.99-
Price to Earnings Ratio13.61-14.11-17.21-16.64-25.84-
Price-to-Total Gains Ratio43.26-40.84-46.16-29.26-61.22-
Price to Book Ratio1.47-1.37-1.67-1.84-2.90-
Price-to-Total Gains Ratio43.26-40.84-46.16-29.26-61.22-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.909288
Number of shares1099
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.020.01
Usd Book Value Change Per Share0.010.01
Usd Total Gains Per Share0.030.03
Gains per Quarter (1099 shares)29.3728.24
Gains per Year (1099 shares)117.46112.97
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
170481074766103
21399622495131216
3209144341142197329
4278192458190262442
5348240575237328555
6417288692285393668
7487336809332459781
8556383926379524894
962643110434275901007
1069547911604746551120

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%40.00.00.0100.0%77.00.09.089.5%
Book Value Change Per Share3.01.00.075.0%9.03.00.075.0%16.04.00.080.0%34.06.00.085.0%68.018.00.079.1%
Dividend per Share3.00.01.075.0%9.00.03.075.0%17.00.03.085.0%30.00.010.075.0%53.00.033.061.6%
Total Gains per Share4.00.00.0100.0%11.01.00.091.7%18.02.00.090.0%38.02.00.095.0%75.011.00.087.2%

Fundamentals of Renhe Pharmacy Co Ltd

About Renhe Pharmacy Co Ltd

Renhe Pharmacy Co., Ltd. produces and sells pharmaceutical products. It offers Chinese and western medicines and raw materials; and health-related products, including oral solid preparations and liquid preparations, large-volume and small-volume injections, external lotions, liniments, suppositories, ointments, and other dosage forms of drugs and health-related products. The company was founded in 1996 and is headquartered in Nanchang, China.

Fundamental data was last updated by Penke on 2024-03-23 03:29:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is underpriced.
Based on how much money comes from the company's main activities, the company is cheap.

1.1. Profitability of Renhe Pharmacy Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Renhe Pharmacy Co Ltd earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Renhe Pharmacy Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 16.2% means that ¥0.16 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Renhe Pharmacy Co Ltd:

  • The MRQ is 16.2%. The company is making a huge profit. +2
  • The TTM is 12.9%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ16.2%TTM12.9%+3.2%
TTM12.9%YOY11.6%+1.3%
TTM12.9%5Y12.7%+0.3%
5Y12.7%10Y12.2%+0.5%
1.1.2. Return on Assets

Shows how efficient Renhe Pharmacy Co Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Renhe Pharmacy Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 2.3% Return on Assets means that Renhe Pharmacy Co Ltd generated ¥0.02 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Renhe Pharmacy Co Ltd:

  • The MRQ is 2.3%. Using its assets, the company is less efficient in making profit.
  • The TTM is 2.1%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ2.3%TTM2.1%+0.2%
TTM2.1%YOY2.1%+0.0%
TTM2.1%5Y2.4%-0.3%
5Y2.4%10Y2.6%-0.1%
1.1.3. Return on Equity

Shows how efficient Renhe Pharmacy Co Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Renhe Pharmacy Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 3.1% Return on Equity means Renhe Pharmacy Co Ltd generated ¥0.03 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Renhe Pharmacy Co Ltd:

  • The MRQ is 3.1%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 2.8%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ3.1%TTM2.8%+0.3%
TTM2.8%YOY2.7%+0.1%
TTM2.8%5Y3.2%-0.4%
5Y3.2%10Y3.4%-0.2%

1.2. Operating Efficiency of Renhe Pharmacy Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Renhe Pharmacy Co Ltd is operating .

  • Measures how much profit Renhe Pharmacy Co Ltd makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Renhe Pharmacy Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 24.6% means the company generated ¥0.25  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Renhe Pharmacy Co Ltd:

  • The MRQ is 24.6%. The company is operating efficient. +1
  • The TTM is 20.4%. The company is operating efficient. +1
Trends
Current periodCompared to+/- 
MRQ24.6%TTM20.4%+4.2%
TTM20.4%YOY17.6%+2.8%
TTM20.4%5Y18.9%+1.5%
5Y18.9%10Y10.3%+8.5%
1.2.2. Operating Ratio

Measures how efficient Renhe Pharmacy Co Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.40 means that the operating costs are ¥1.40 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Renhe Pharmacy Co Ltd:

  • The MRQ is 1.396. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.421. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.396TTM1.421-0.025
TTM1.421YOY1.457-0.036
TTM1.4215Y1.419+0.002
5Y1.41910Y1.034+0.386

1.3. Liquidity of Renhe Pharmacy Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Renhe Pharmacy Co Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 4.37 means the company has ¥4.37 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Renhe Pharmacy Co Ltd:

  • The MRQ is 4.374. The company is very able to pay all its short-term debts. +2
  • The TTM is 4.366. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ4.374TTM4.366+0.008
TTM4.366YOY4.694-0.328
TTM4.3665Y4.643-0.277
5Y4.64310Y2.492+2.151
1.3.2. Quick Ratio

Measures if Renhe Pharmacy Co Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Renhe Pharmacy Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 2.48 means the company can pay off ¥2.48 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Renhe Pharmacy Co Ltd:

  • The MRQ is 2.484. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 2.023. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.484TTM2.023+0.461
TTM2.023YOY2.330-0.307
TTM2.0235Y1.628+0.395
5Y1.62810Y1.303+0.325

1.4. Solvency of Renhe Pharmacy Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Renhe Pharmacy Co Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Renhe Pharmacy Co Ltd to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.15 means that Renhe Pharmacy Co Ltd assets are financed with 14.7% credit (debt) and the remaining percentage (100% - 14.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Renhe Pharmacy Co Ltd:

  • The MRQ is 0.147. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.144. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.147TTM0.144+0.002
TTM0.144YOY0.129+0.016
TTM0.1445Y0.138+0.006
5Y0.13810Y0.154-0.016
1.4.2. Debt to Equity Ratio

Measures if Renhe Pharmacy Co Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Renhe Pharmacy Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 19.5% means that company has ¥0.19 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Renhe Pharmacy Co Ltd:

  • The MRQ is 0.195. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.190. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.195TTM0.190+0.005
TTM0.190YOY0.167+0.023
TTM0.1905Y0.182+0.008
5Y0.18210Y0.206-0.025

2. Market Valuation of Renhe Pharmacy Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Renhe Pharmacy Co Ltd generates.

  • Above 15 is considered overpriced but always compare Renhe Pharmacy Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 13.61 means the investor is paying ¥13.61 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Renhe Pharmacy Co Ltd:

  • The EOD is 12.509. Based on the earnings, the company is underpriced. +1
  • The MRQ is 13.613. Based on the earnings, the company is underpriced. +1
  • The TTM is 14.115. Based on the earnings, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD12.509MRQ13.613-1.104
MRQ13.613TTM14.115-0.502
TTM14.115YOY17.207-3.092
TTM14.1155Y16.643-2.528
5Y16.64310Y25.843-9.200
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Renhe Pharmacy Co Ltd:

  • The EOD is 36.070. Based on how much money comes from the company's main activities, the company is fair priced.
  • The MRQ is 39.255. Based on how much money comes from the company's main activities, the company is fair priced.
  • The TTM is 10.222. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD36.070MRQ39.255-3.184
MRQ39.255TTM10.222+29.032
TTM10.222YOY15.954-5.732
TTM10.2225Y-23.729+33.951
5Y-23.72910Y7.109-30.838
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Renhe Pharmacy Co Ltd is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Renhe Pharmacy Co Ltd:

  • The EOD is 1.352. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.472. Based on the equity, the company is underpriced. +1
  • The TTM is 1.366. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.352MRQ1.472-0.119
MRQ1.472TTM1.366+0.106
TTM1.366YOY1.668-0.302
TTM1.3665Y1.845-0.479
5Y1.84510Y2.904-1.059
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Renhe Pharmacy Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.1650.079+110%0.136+22%0.108+53%0.087+89%
Book Value Per Share--4.8584.721+3%4.388+11%3.845+26%2.930+66%
Current Ratio--4.3744.366+0%4.694-7%4.643-6%2.492+76%
Debt To Asset Ratio--0.1470.144+2%0.129+14%0.138+6%0.154-5%
Debt To Equity Ratio--0.1950.190+2%0.167+17%0.182+7%0.206-6%
Dividend Per Share---0.114-100%0.026-100%0.078-100%0.055-100%
Eps--0.1310.118+12%0.107+23%0.107+23%0.086+52%
Free Cash Flow Per Share--0.0460.177-74%0.055-17%0.104-56%0.114-60%
Free Cash Flow To Equity Per Share--0.0460.061-25%0.027+74%0.072-36%0.096-52%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--5.436--------
Intrinsic Value_10Y_min--3.635--------
Intrinsic Value_1Y_max--0.470--------
Intrinsic Value_1Y_min--0.432--------
Intrinsic Value_3Y_max--1.469--------
Intrinsic Value_3Y_min--1.247--------
Intrinsic Value_5Y_max--2.537--------
Intrinsic Value_5Y_min--2.000--------
Market Cap9197605589.760-9%10009570771.2009033112643.520+11%10191562967.040-2%9695070764.226+3%10081910922.465-1%
Net Profit Margin--0.1620.129+25%0.116+39%0.127+28%0.122+33%
Operating Margin--0.2460.204+21%0.176+40%0.189+30%0.103+138%
Operating Ratio--1.3961.421-2%1.457-4%1.419-2%1.034+35%
Pb Ratio1.352-9%1.4721.366+8%1.668-12%1.845-20%2.904-49%
Pe Ratio12.509-9%13.61314.115-4%17.207-21%16.643-18%25.843-47%
Price Per Share6.570-9%7.1506.453+11%7.280-2%6.889+4%7.1830%
Price To Free Cash Flow Ratio36.070-9%39.25510.222+284%15.954+146%-23.729+160%7.109+452%
Price To Total Gains Ratio39.755-9%43.26440.844+6%46.159-6%29.260+48%61.219-29%
Quick Ratio--2.4842.023+23%2.330+7%1.628+53%1.303+91%
Return On Assets--0.0230.021+8%0.021+9%0.024-5%0.026-10%
Return On Equity--0.0310.028+9%0.027+12%0.032-4%0.034-11%
Total Gains Per Share--0.1650.193-14%0.161+2%0.186-11%0.143+16%
Usd Book Value--941316821.231914628682.938+3%850218979.979+11%747776079.606+26%569027627.815+65%
Usd Book Value Change Per Share--0.0230.011+110%0.019+22%0.015+53%0.012+89%
Usd Book Value Per Share--0.6720.653+3%0.607+11%0.532+26%0.405+66%
Usd Dividend Per Share---0.016-100%0.004-100%0.011-100%0.008-100%
Usd Eps--0.0180.016+12%0.015+23%0.015+23%0.012+52%
Usd Free Cash Flow--8822695.42634280271.695-74%10573244.053-17%20103410.168-56%21558593.788-59%
Usd Free Cash Flow Per Share--0.0060.024-74%0.008-17%0.014-56%0.016-60%
Usd Free Cash Flow To Equity Per Share--0.0060.008-25%0.004+74%0.010-36%0.013-52%
Usd Market Cap1272948613.623-9%1385324594.7341250182789.863+11%1410512314.638-2%1341797793.769+3%1395336471.669-1%
Usd Price Per Share0.909-9%0.9900.893+11%1.008-2%0.953+4%0.9940%
Usd Profit--25441616.02922779250.166+12%20648057.410+23%20760517.560+23%16781750.664+52%
Usd Revenue--157329494.662177363975.818-11%177222934.792-11%163741299.703-4%137345223.215+15%
Usd Total Gains Per Share--0.0230.027-14%0.022+2%0.026-11%0.020+16%
 EOD+4 -4MRQTTM+20 -15YOY+21 -145Y+18 -1710Y+20 -15

3.2. Fundamental Score

Let's check the fundamental score of Renhe Pharmacy Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1512.509
Price to Book Ratio (EOD)Between0-11.352
Net Profit Margin (MRQ)Greater than00.162
Operating Margin (MRQ)Greater than00.246
Quick Ratio (MRQ)Greater than12.484
Current Ratio (MRQ)Greater than14.374
Debt to Asset Ratio (MRQ)Less than10.147
Debt to Equity Ratio (MRQ)Less than10.195
Return on Equity (MRQ)Greater than0.150.031
Return on Assets (MRQ)Greater than0.050.023
Total7/10 (70.0%)

3.3. Technical Score

Let's check the technical score of Renhe Pharmacy Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5055.299
Ma 20Greater thanMa 506.527
Ma 50Greater thanMa 1006.291
Ma 100Greater thanMa 2006.557
OpenGreater thanClose6.520
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2023-09-30. Currency in CNY. All numbers in thousands.

Summary
Total Assets7,970,195
Total Liabilities1,168,773
Total Stockholder Equity6,001,177
 As reported
Total Liabilities 1,168,773
Total Stockholder Equity+ 6,001,177
Total Assets = 7,970,195

Assets

Total Assets7,970,195
Total Current Assets4,915,678
Long-term Assets3,054,517
Total Current Assets
Cash And Cash Equivalents 1,227,294
Short-term Investments 1,884,046
Net Receivables 907,937
Inventory 463,691
Other Current Assets 92,676
Total Current Assets  (as reported)4,915,678
Total Current Assets  (calculated)4,575,644
+/- 340,034
Long-term Assets
Property Plant Equipment 1,232,641
Goodwill 578,237
Intangible Assets 609,595
Other Assets 105,215
Long-term Assets  (as reported)3,054,517
Long-term Assets  (calculated)2,525,688
+/- 528,830

Liabilities & Shareholders' Equity

Total Current Liabilities1,123,928
Long-term Liabilities44,846
Total Stockholder Equity6,001,177
Total Current Liabilities
Accounts payable 434,993
Other Current Liabilities 663,030
Total Current Liabilities  (as reported)1,123,928
Total Current Liabilities  (calculated)1,098,023
+/- 25,904
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt5,793
Other Liabilities 39,053
Long-term Liabilities  (as reported)44,846
Long-term Liabilities  (calculated)44,846
+/- 0
Total Stockholder Equity
Common Stock1,399,938
Retained Earnings 3,815,481
Total Stockholder Equity (as reported)6,001,177
Total Stockholder Equity (calculated)5,215,419
+/- 785,758
Other
Capital Stock1,399,938
Common Stock Shares Outstanding 1,399,938
Net Invested Capital 6,001,177
Net Tangible Assets 4,835,901
Net Working Capital 3,791,750
Property Plant and Equipment Gross 1,232,641



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-06-302000-12-312000-06-30
> Total Assets 
552,527
651,614
634,701
711,942
719,698
737,255
746,550
759,664
762,111
770,740
780,439
679,381
685,692
695,036
641,635
600,726
597,275
621,856
574,866
455,999
424,101
419,702
412,295
271,721
275,615
294,989
323,726
308,483
301,777
345,165
370,642
437,802
436,205
419,302
886,541
1,060,882
1,027,499
970,652
1,292,835
1,478,181
1,445,119
1,415,858
1,554,251
1,602,790
1,627,076
2,407,081
1,864,540
2,094,866
2,168,390
2,250,215
2,284,812
2,328,717
2,334,366
2,381,907
2,473,913
2,597,104
2,661,766
2,809,621
2,958,915
3,156,271
3,703,370
3,710,296
3,675,797
3,864,896
3,828,507
3,893,783
4,035,910
4,167,392
4,348,203
4,488,104
4,618,493
4,616,658
4,862,955
4,948,047
5,036,770
4,984,426
5,125,804
5,183,399
5,347,057
6,305,052
6,578,632
6,452,817
6,738,670
6,907,892
7,067,967
7,015,682
7,211,810
7,631,644
7,674,834
7,618,991
7,970,195
7,970,1957,618,9917,674,8347,631,6447,211,8107,015,6827,067,9676,907,8926,738,6706,452,8176,578,6326,305,0525,347,0575,183,3995,125,8044,984,4265,036,7704,948,0474,862,9554,616,6584,618,4934,488,1044,348,2034,167,3924,035,9103,893,7833,828,5073,864,8963,675,7973,710,2963,703,3703,156,2712,958,9152,809,6212,661,7662,597,1042,473,9132,381,9072,334,3662,328,7172,284,8122,250,2152,168,3902,094,8661,864,5402,407,0811,627,0761,602,7901,554,2511,415,8581,445,1191,478,1811,292,835970,6521,027,4991,060,882886,541419,302436,205437,802370,642345,165301,777308,483323,726294,989275,615271,721412,295419,702424,101455,999574,866621,856597,275600,726641,635695,036685,692679,381780,439770,740762,111759,664746,550737,255719,698711,942634,701651,614552,527
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,733,079
2,877,341
2,905,393
3,154,539
3,247,092
3,389,520
3,319,677
3,422,095
3,487,148
3,633,885
3,833,462
3,741,834
3,659,831
3,996,605
4,055,656
4,240,656
4,148,220
4,170,021
4,580,859
4,503,673
4,618,700
4,915,678
4,915,6784,618,7004,503,6734,580,8594,170,0214,148,2204,240,6564,055,6563,996,6053,659,8313,741,8343,833,4623,633,8853,487,1483,422,0953,319,6773,389,5203,247,0923,154,5392,905,3932,877,3412,733,079000000000000000000000000000000000000000000000000000000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,449,806
1,466,956
1,756,215
1,735,561
1,882,498
1,912,070
1,419,240
2,119,678
2,296,122
2,347,326
1,707,886
1,175,781
993,025
1,329,068
2,360,423
1,288,795
1,559,359
665,241
2,825,477
1,027,984
1,310,007
1,227,294
1,227,2941,310,0071,027,9842,825,477665,2411,559,3591,288,7952,360,4231,329,068993,0251,175,7811,707,8862,347,3262,296,1222,119,6781,419,2401,912,0701,882,4981,735,5611,756,2151,466,9561,449,806000000000000000000000000000000000000000000000000000000000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,500
8,348
5,787
8,783
805,141
11,221
9,248
4,502
460,892
458,461
615,065
831,866
315,597
1,351,740
1,180,661
2,011,667
416,873
1,715,801
1,620,758
1,884,046
1,884,0461,620,7581,715,801416,8732,011,6671,180,6611,351,740315,597831,866615,065458,461460,8924,5029,24811,221805,1418,7835,7878,3483,50000000000000000000000000000000000000000000000000000000000000000000000000
       Net Receivables 
9,932
21,755
24,720
171,592
0
194,061
245,838
206,148
222,368
224,171
272,079
162,525
213,042
241,342
204,984
153,384
181,111
164,874
189,507
114,532
89,644
99,890
95,265
27,889
15,404
12,702
101,242
79,341
95,604
128,482
81,978
134,075
123,365
109,454
146,911
245,841
198,983
147,272
380,203
596,666
432,377
450,773
548,605
610,724
592,558
408,684
238,385
421,607
480,813
472,676
536,237
404,853
438,495
365,192
450,852
439,417
429,573
362,316
503,975
520,109
700,540
602,015
656,691
435,349
618,169
536,035
683,744
486,151
692,230
673,752
800,339
523,258
717,185
605,351
744,280
522,578
758,159
656,213
781,230
453,830
763,295
691,248
980,373
549,821
892,103
819,064
978,224
486,407
728,302
749,213
907,937
907,937749,213728,302486,407978,224819,064892,103549,821980,373691,248763,295453,830781,230656,213758,159522,578744,280605,351717,185523,258800,339673,752692,230486,151683,744536,035618,169435,349656,691602,015700,540520,109503,975362,316429,573439,417450,852365,192438,495404,853536,237472,676480,813421,607238,385408,684592,558610,724548,605450,773432,377596,666380,203147,272198,983245,841146,911109,454123,365134,07581,978128,48295,60479,341101,24212,70215,40427,88995,26599,89089,644114,532189,507164,874181,111153,384204,984241,342213,042162,525272,079224,171222,368206,148245,838194,0610171,59224,72021,7559,932
       Inventory 
47,094
78,859
58,927
63,000
0
71,593
67,330
68,803
68,727
69,127
65,430
84,356
80,173
75,660
78,099
86,379
67,686
97,939
73,605
40,832
28,771
30,381
29,798
61,965
97,347
114,076
41,574
17,774
19,438
29,978
28,710
27,828
41,513
34,057
46,599
38,725
37,223
41,481
109,675
138,779
191,947
144,417
188,069
160,350
138,606
269,306
154,202
200,954
222,935
246,634
239,404
251,671
208,999
276,790
291,019
303,401
295,197
341,445
343,377
369,087
392,548
456,230
413,370
456,994
383,575
390,171
378,430
455,897
401,629
508,780
477,254
533,051
432,090
486,992
503,742
522,947
464,608
438,112
417,503
451,718
377,342
515,293
545,749
601,352
527,686
509,511
418,844
457,736
443,725
441,609
463,691
463,691441,609443,725457,736418,844509,511527,686601,352545,749515,293377,342451,718417,503438,112464,608522,947503,742486,992432,090533,051477,254508,780401,629455,897378,430390,171383,575456,994413,370456,230392,548369,087343,377341,445295,197303,401291,019276,790208,999251,671239,404246,634222,935200,954154,202269,306138,606160,350188,069144,417191,947138,779109,67541,48137,22338,72546,59934,05741,51327,82828,71029,97819,43817,77441,574114,07697,34761,96529,79830,38128,77140,83273,60597,93967,68686,37978,09975,66080,17384,35665,43069,12768,72768,80367,33071,593063,00058,92778,85947,094
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,708,417
1,700,955
1,647,250
1,664,750
1,703,709
1,696,251
1,713,172
2,471,590
2,836,797
2,792,986
2,742,064
2,852,236
2,827,311
2,867,461
3,041,789
3,050,785
3,171,162
3,000,291
3,054,517
3,054,5173,000,2913,171,1623,050,7853,041,7892,867,4612,827,3112,852,2362,742,0642,792,9862,836,7972,471,5901,713,1721,696,2511,703,7091,664,7501,647,2501,700,9551,708,417000000000000000000000000000000000000000000000000000000000000000000000000
       Property Plant Equipment 
314,934
338,182
350,738
344,345
0
340,515
336,017
329,530
327,141
323,410
319,802
318,359
313,288
316,109
317,577
314,354
309,674
308,460
302,919
292,723
0
282,112
277,183
93,455
23,941
93,150
24,994
92,926
24,993
92,006
25,112
109,064
24,204
107,265
117,965
344,531
124,997
345,587
138,292
380,980
157,375
379,899
167,598
442,204
239,323
757,696
417,391
797,485
464,528
828,691
500,960
865,352
537,264
541,643
555,989
559,028
560,763
557,329
556,341
649,288
736,517
731,891
724,031
721,613
714,826
703,756
691,795
679,737
666,241
654,669
643,775
631,809
619,728
608,175
613,681
629,787
654,916
658,293
688,108
743,987
777,118
778,859
867,306
1,111,575
1,139,072
1,140,861
1,199,848
1,240,729
1,259,679
1,253,054
1,232,641
1,232,6411,253,0541,259,6791,240,7291,199,8481,140,8611,139,0721,111,575867,306778,859777,118743,987688,108658,293654,916629,787613,681608,175619,728631,809643,775654,669666,241679,737691,795703,756714,826721,613724,031731,891736,517649,288556,341557,329560,763559,028555,989541,643537,264865,352500,960828,691464,528797,485417,391757,696239,323442,204167,598379,899157,375380,980138,292345,587124,997344,531117,965107,26524,204109,06425,11292,00624,99392,92624,99493,15023,94193,455277,183282,1120292,723302,919308,460309,674314,354317,577316,109313,288318,359319,802323,410327,141329,530336,017340,5150344,345350,738338,182314,934
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
95,708
95,708
95,689
102,204
102,204
102,204
102,204
131,066
427,250
427,538
426,382
437,827
437,827
437,827
435,127
420,013
420,013
420,013
419,780
377,851
377,851
377,851
304,459
102,204
102,204
102,204
102,204
102,204
102,204
102,204
621,587
606,124
606,124
606,124
606,124
578,237
578,237
578,237
578,237
578,237578,237578,237578,237606,124606,124606,124606,124621,587102,204102,204102,204102,204102,204102,204102,204304,459377,851377,851377,851419,780420,013420,013420,013435,127437,827437,827437,827426,382427,538427,250131,066102,204102,204102,204102,20495,68995,70895,7080000000000000000000000000000000000000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,100
100
0
20,000
21,000
24,050
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000024,05021,00020,00001003,100000000000000000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
0
22
23
22
0
20
20
23
23
19
23
18
22
21
21
19
19
18
18
17
0
15
14
37,825
105,598
35,829
102,968
33,595
100,111
31,404
115,277
29,158
112,239
27,815
248,781
26,495
244,860
23,944
251,434
28,547
260,649
40,453
269,396
36,406
263,570
37,864
544,956
72,905
515,685
69,202
503,254
84,265
510,331
506,116
501,906
500,819
496,583
492,745
489,120
506,516
1,115,153
1,111,499
1,109,093
813,482
810,145
806,498
800,954
795,005
788,496
367,541
363,160
360,488
664,794
369,461
673,111
666,174
672,096
667,959
663,469
664,500
659,923
660,605
654,672
650,633
646,335
622,922
620,448
602,202
630,052
620,646
609,595
609,595620,646630,052602,202620,448622,922646,335650,633654,672660,605659,923664,500663,469667,959672,096666,174673,111369,461664,794360,488363,160367,541788,496795,005800,954806,498810,145813,4821,109,0931,111,4991,115,153506,516489,120492,745496,583500,819501,906506,116510,33184,265503,25469,202515,68572,905544,95637,864263,57036,406269,39640,453260,64928,547251,43423,944244,86026,495248,78127,815112,23929,158115,27731,404100,11133,595102,96835,829105,59837,8251415017181819192121221823192323202002223220
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
16,405
4,170
20,726
17,269
26,594
24,105
709,395
21,072
26,576
27,163
30,289
59,560
60,648
53,147
50,118
51,719
42,524
36,357
44,114
44,11436,35742,52451,71950,11853,14760,64859,56030,28927,16326,57621,072709,39524,10526,59417,26920,7264,17016,405000000000000000000000000000000000000000000000000000000000000000000000000
> Total Liabilities 
279,398
306,291
288,560
380,359
388,042
404,527
412,237
420,925
420,470
425,584
434,281
441,209
446,888
455,998
416,381
431,681
434,362
457,406
413,414
409,115
397,578
403,565
409,556
77,014
65,623
77,544
96,405
73,044
55,523
85,901
93,992
132,201
112,467
72,648
100,467
203,720
117,340
106,003
371,915
566,133
453,526
450,479
521,994
460,680
380,845
1,133,042
250,698
382,801
371,510
379,156
372,656
389,864
346,446
421,648
429,235
435,059
418,496
489,219
525,422
555,411
780,818
693,478
570,785
660,414
528,274
605,720
666,095
694,947
758,876
835,049
833,350
701,674
782,065
792,954
794,261
632,470
657,848
677,661
729,364
694,536
791,162
734,562
1,138,762
980,999
946,808
851,172
851,568
1,209,856
1,033,752
1,048,929
1,168,773
1,168,7731,048,9291,033,7521,209,856851,568851,172946,808980,9991,138,762734,562791,162694,536729,364677,661657,848632,470794,261792,954782,065701,674833,350835,049758,876694,947666,095605,720528,274660,414570,785693,478780,818555,411525,422489,219418,496435,059429,235421,648346,446389,864372,656379,156371,510382,801250,6981,133,042380,845460,680521,994450,479453,526566,133371,915106,003117,340203,720100,46772,648112,467132,20193,99285,90155,52373,04496,40577,54465,62377,014409,556403,565397,578409,115413,414457,406434,362431,681416,381455,998446,888441,209434,281425,584420,470420,925412,237404,527388,042380,359288,560306,291279,398
   > Total Current Liabilities 
74,138
101,031
83,300
174,729
182,412
198,897
206,607
251,095
250,160
255,420
264,263
297,987
303,671
312,831
278,214
428,765
431,105
455,519
411,527
406,555
395,018
401,005
406,596
77,014
65,623
77,544
96,405
73,044
55,523
85,901
93,992
132,201
112,467
72,648
100,467
203,720
117,340
106,003
371,915
566,133
453,526
450,479
521,994
460,680
380,845
1,127,574
245,230
363,759
352,468
360,159
353,659
370,646
328,713
403,915
411,503
415,613
399,050
469,773
505,976
538,218
763,625
676,284
553,592
646,124
513,984
591,429
651,805
683,007
747,070
823,373
821,795
691,047
771,563
782,692
784,025
623,144
646,995
668,616
720,438
684,709
781,464
725,025
1,129,291
968,662
924,931
830,573
832,245
1,164,511
988,574
1,003,917
1,123,928
1,123,9281,003,917988,5741,164,511832,245830,573924,931968,6621,129,291725,025781,464684,709720,438668,616646,995623,144784,025782,692771,563691,047821,795823,373747,070683,007651,805591,429513,984646,124553,592676,284763,625538,218505,976469,773399,050415,613411,503403,915328,713370,646353,659360,159352,468363,759245,2301,127,574380,845460,680521,994450,479453,526566,133371,915106,003117,340203,720100,46772,648112,467132,20193,99285,90155,52373,04496,40577,54465,62377,014406,596401,005395,018406,555411,527455,519431,105428,765278,214312,831303,671297,987264,263255,420250,160251,095206,607198,897182,412174,72983,300101,03174,138
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
60,000
60,000
60,051
60,051
0
0
0
0
0
0
0
0
0
0
000000000060,05160,05160,00060,00000000000000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
22,122
46,294
28,415
47,112
0
74,091
71,707
72,169
60,889
65,846
60,965
60,190
59,066
74,043
70,697
92,638
89,998
108,281
75,125
62,220
42,206
39,638
39,286
10,754
7,881
8,012
17,505
40,302
22,639
9,567
12,183
19,744
24,087
29,768
35,672
44,386
45,145
41,906
160,405
278,910
289,151
268,324
278,302
202,573
218,313
276,023
110,249
149,279
166,098
182,619
158,856
152,187
113,149
186,456
182,076
180,583
160,965
213,828
226,199
229,660
329,940
330,673
268,598
236,805
182,996
233,258
229,050
223,750
249,637
280,417
227,673
213,708
251,131
261,215
250,163
142,191
212,222
149,191
165,858
147,237
200,456
207,370
248,142
176,075
226,079
229,463
213,025
199,616
258,156
403,990
434,993
434,993403,990258,156199,616213,025229,463226,079176,075248,142207,370200,456147,237165,858149,191212,222142,191250,163261,215251,131213,708227,673280,417249,637223,750229,050233,258182,996236,805268,598330,673329,940229,660226,199213,828160,965180,583182,076186,456113,149152,187158,856182,619166,098149,279110,249276,023218,313202,573278,302268,324289,151278,910160,40541,90645,14544,38635,67229,76824,08719,74412,1839,56722,63940,30217,5058,0127,88110,75439,28639,63842,20662,22075,125108,28189,99892,63870,69774,04359,06660,19060,96565,84660,88972,16971,70774,091047,11228,41546,29422,122
       Other Current Liabilities 
34,016
30,407
30,555
23,317
182,412
27,506
30,600
22,626
32,971
33,274
26,998
20,797
27,605
21,788
27,517
20,087
25,067
31,198
23,081
32,076
352,812
43,510
46,810
66,260
57,742
69,532
78,900
32,742
32,884
76,334
81,809
112,457
88,380
42,880
64,795
159,334
72,195
64,097
208,310
267,223
144,375
162,155
223,692
238,107
142,532
803,551
134,981
214,480
186,370
177,540
194,803
218,459
215,564
213,706
229,427
235,030
238,085
252,432
279,776
308,558
433,685
345,612
284,994
409,319
330,987
358,171
422,755
459,257
497,432
436,416
585,804
401,014
510,592
400,486
526,827
409,159
429,136
377,159
489,905
409,166
515,249
423,166
870,300
679,039
683,861
589,041
608,438
939,552
714,108
490,359
663,030
663,030490,359714,108939,552608,438589,041683,861679,039870,300423,166515,249409,166489,905377,159429,136409,159526,827400,486510,592401,014585,804436,416497,432459,257422,755358,171330,987409,319284,994345,612433,685308,558279,776252,432238,085235,030229,427213,706215,564218,459194,803177,540186,370214,480134,981803,551142,532238,107223,692162,155144,375267,223208,31064,09772,195159,33464,79542,88088,380112,45781,80976,33432,88432,74278,90069,53257,74266,26046,81043,510352,81232,07623,08131,19825,06720,08727,51721,78827,60520,79726,99833,27432,97122,62630,60027,506182,41223,31730,55530,40734,016
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
10,502
10,262
10,236
9,326
10,852
9,045
8,925
9,828
9,698
9,536
9,471
12,338
21,877
20,599
19,322
45,345
45,178
45,012
44,846
44,84645,01245,17845,34519,32220,59921,87712,3389,4719,5369,6989,8288,9259,04510,8529,32610,23610,26210,502000000000000000000000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
370
205,630
370
370
570
1,050
904
758
962
957
907
907
2,916
3,257
1,887
1,887
2,560
2,560
2,560
2,960
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,468
5,468
19,042
19,042
18,997
18,997
17,733
17,733
17,733
17,733
18,401
18,401
18,401
18,401
16,273
16,273
16,273
16,273
13,823
13,823
13,823
13,823
11,558
11,438
11,676
11,556
10,627
10,502
10,262
10,236
9,326
10,852
9,045
8,925
9,828
9,698
9,536
9,471
8,717
8,555
8,394
8,232
39,552
39,385
39,219
39,053
39,05339,21939,38539,5528,2328,3948,5558,7179,4719,5369,6989,8288,9259,04510,8529,32610,23610,26210,50210,62711,55611,67611,43811,55813,82313,82313,82313,82316,27316,27316,27316,27318,40118,40118,40118,40117,73317,73317,73317,73318,99718,99719,04219,0425,4685,46800000000000000000000002,9602,5602,5602,5601,8871,8873,2572,9169079079579627589041,050570370370205,630370000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
292,181
300,319
306,229
311,567
310,911
310,695
309,366
308,984
308,296
308,468
310,472
309,517
310,892
312,007
310,642
312,241
312,420
311,407
19,335
25,114
26,815
26,191
26,19126,81525,11419,335311,407312,420312,241310,642312,007310,892309,517310,472308,468308,296308,984309,366310,695310,911311,567306,229300,319292,181000000000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
273,129
345,323
346,141
331,583
331,656
332,729
334,313
338,738
341,641
345,156
346,158
238,172
238,804
239,038
225,254
169,045
162,913
164,450
161,452
46,884
26,523
16,138
2,739
194,707
209,992
217,445
227,321
235,439
246,254
259,264
276,649
305,600
323,738
346,654
786,074
856,380
909,317
863,423
901,363
874,055
951,417
942,524
1,008,482
1,116,947
1,219,558
1,152,711
1,507,829
1,620,753
1,702,345
1,770,788
1,802,381
1,826,424
1,870,936
1,844,039
1,919,145
2,032,944
2,106,775
2,168,676
2,268,158
2,389,015
2,492,930
2,566,395
2,659,489
2,751,851
2,831,228
2,789,570
2,886,497
3,008,550
3,114,956
3,129,090
3,277,630
3,391,558
3,534,358
3,589,607
3,706,495
3,805,551
3,908,758
3,923,868
4,051,920
5,072,896
5,222,935
5,121,521
5,006,119
5,287,243
5,442,938
5,464,537
5,621,029
5,740,789
5,923,088
5,817,350
6,001,177
6,001,1775,817,3505,923,0885,740,7895,621,0295,464,5375,442,9385,287,2435,006,1195,121,5215,222,9355,072,8964,051,9203,923,8683,908,7583,805,5513,706,4953,589,6073,534,3583,391,5583,277,6303,129,0903,114,9563,008,5502,886,4972,789,5702,831,2282,751,8512,659,4892,566,3952,492,9302,389,0152,268,1582,168,6762,106,7752,032,9441,919,1451,844,0391,870,9361,826,4241,802,3811,770,7881,702,3451,620,7531,507,8291,152,7111,219,5581,116,9471,008,482942,524951,417874,055901,363863,423909,317856,380786,074346,654323,738305,600276,649259,264246,254235,439227,321217,445209,992194,7072,73916,13826,52346,884161,452164,450162,913169,045225,254239,038238,804238,172346,158345,156341,641338,738334,313332,729331,656331,583346,141345,323273,129
   Common Stock
102,744
111,168
200,102
200,102
0
200,102
200,102
200,102
200,102
200,102
200,102
200,102
200,102
200,102
200,102
200,102
200,102
200,102
200,102
200,102
200,102
200,102
200,102
200,102
220,110
220,110
220,110
220,110
220,110
220,110
220,110
220,110
220,110
220,110
280,110
280,110
280,110
420,165
420,165
420,165
420,165
630,248
630,248
630,248
630,248
945,372
990,672
990,672
990,672
990,672
990,672
990,672
990,672
990,672
990,672
990,672
990,672
1,238,340
1,238,340
1,238,340
1,238,340
1,238,340
1,238,340
1,238,340
1,238,340
1,238,340
1,238,340
1,238,340
1,238,340
1,238,340
1,238,340
1,238,340
1,238,340
1,238,340
1,238,340
1,238,340
1,238,340
1,238,340
1,238,340
1,399,938
1,399,938
1,399,938
1,399,938
1,399,938
1,399,938
1,399,938
1,399,938
1,399,938
1,399,938
1,399,938
1,399,938
1,399,9381,399,9381,399,9381,399,9381,399,9381,399,9381,399,9381,399,9381,399,9381,399,9381,399,9381,399,9381,238,3401,238,3401,238,3401,238,3401,238,3401,238,3401,238,3401,238,3401,238,3401,238,3401,238,3401,238,3401,238,3401,238,3401,238,3401,238,3401,238,3401,238,3401,238,3401,238,3401,238,3401,238,340990,672990,672990,672990,672990,672990,672990,672990,672990,672990,672990,672945,372630,248630,248630,248630,248420,165420,165420,165420,165280,110280,110280,110220,110220,110220,110220,110220,110220,110220,110220,110220,110220,110200,102200,102200,102200,102200,102200,102200,102200,102200,102200,102200,102200,102200,102200,102200,102200,102200,102200,102200,1020200,102200,102111,168102,744
   Retained Earnings 
77,184
80,252
58,714
43,505
0
44,651
46,235
50,577
53,480
56,996
57,997
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,601
22,738
45,655
97,157
261,155
314,091
268,198
306,137
392,760
470,123
269,218
333,486
417,688
520,299
137,615
143,022
230,675
312,267
380,711
412,303
401,284
575,430
548,532
623,632
732,758
806,589
620,822
720,304
846,673
950,589
1,024,054
1,117,147
1,219,053
1,298,431
1,256,772
1,353,699
1,475,446
1,581,852
1,595,986
1,744,381
1,858,076
1,749,802
1,806,924
1,922,844
2,272,069
2,375,276
2,390,386
2,518,438
2,716,946
2,866,984
2,765,571
2,980,524
3,120,645
3,276,341
3,280,617
3,437,109
3,555,093
3,737,392
3,631,654
3,815,481
3,815,4813,631,6543,737,3923,555,0933,437,1093,280,6173,276,3413,120,6452,980,5242,765,5712,866,9842,716,9462,518,4382,390,3862,375,2762,272,0691,922,8441,806,9241,749,8021,858,0761,744,3811,595,9861,581,8521,475,4461,353,6991,256,7721,298,4311,219,0531,117,1471,024,054950,589846,673720,304620,822806,589732,758623,632548,532575,430401,284412,303380,711312,267230,675143,022137,615520,299417,688333,486269,218470,123392,760306,137268,198314,091261,15597,15745,65522,7384,6010000000000000000000057,99756,99653,48050,57746,23544,651043,50558,71480,25277,184
   Capital Surplus 0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue5,126,126
Cost of Revenue-3,179,356
Gross Profit1,946,7711,946,771
 
Operating Income (+$)
Gross Profit1,946,771
Operating Expense-4,107,860
Operating Income1,018,267-2,161,089
 
Operating Expense (+$)
Research Development40,413
Selling General Administrative638,592
Selling And Marketing Expenses-
Operating Expense4,107,860679,005
 
Net Interest Income (+$)
Interest Income23,206
Interest Expense-376
Other Finance Cost-1,450
Net Interest Income21,380
 
Pretax Income (+$)
Operating Income1,018,267
Net Interest Income21,380
Other Non-Operating Income Expenses-
Income Before Tax (EBT)1,061,7091,018,267
EBIT - interestExpense = -376
658,360
658,736
Interest Expense376
Earnings Before Interest and Taxes (EBIT)-1,062,085
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax1,061,709
Tax Provision-264,640
Net Income From Continuing Ops797,070797,070
Net Income658,360
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net--21,380
 

Technical Analysis of Renhe Pharmacy Co Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Renhe Pharmacy Co Ltd. The general trend of Renhe Pharmacy Co Ltd is NEUTRAL with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Renhe Pharmacy Co Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (0.0%) Bearish trend (0.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Renhe Pharmacy Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 6.72 < 6.73 < 6.86.

The bearish price targets are: 6.31 > 5.2037096654275 > 5.1649731397459.

Tweet this
Renhe Pharmacy Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Renhe Pharmacy Co Ltd. The current mas is .

The long score for the Moving Averages is 7/14.
The longshort score for the Moving Averages is 0/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Renhe Pharmacy Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Renhe Pharmacy Co Ltd. The current macd is 0.06205943.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Renhe Pharmacy Co Ltd price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Renhe Pharmacy Co Ltd. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Renhe Pharmacy Co Ltd price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Renhe Pharmacy Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartRenhe Pharmacy Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Renhe Pharmacy Co Ltd. The current adx is 21.17.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Renhe Pharmacy Co Ltd shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Renhe Pharmacy Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Renhe Pharmacy Co Ltd. The current sar is 6.6959873.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Renhe Pharmacy Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Renhe Pharmacy Co Ltd. The current rsi is 55.30. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending up: The RSI is trending up. +1
Renhe Pharmacy Co Ltd Daily Relative Strength Index (RSI) ChartRenhe Pharmacy Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Renhe Pharmacy Co Ltd. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Renhe Pharmacy Co Ltd price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Renhe Pharmacy Co Ltd Daily Stochastic Oscillator ChartRenhe Pharmacy Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Renhe Pharmacy Co Ltd. The current cci is 14.30.

Renhe Pharmacy Co Ltd Daily Commodity Channel Index (CCI) ChartRenhe Pharmacy Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Renhe Pharmacy Co Ltd. The current cmo is 10.42.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Renhe Pharmacy Co Ltd Daily Chande Momentum Oscillator (CMO) ChartRenhe Pharmacy Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Renhe Pharmacy Co Ltd. The current willr is -51.61290323.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Renhe Pharmacy Co Ltd is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Renhe Pharmacy Co Ltd Daily Williams %R ChartRenhe Pharmacy Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Renhe Pharmacy Co Ltd.

Renhe Pharmacy Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Renhe Pharmacy Co Ltd. The current atr is 0.1520987.

Renhe Pharmacy Co Ltd Daily Average True Range (ATR) ChartRenhe Pharmacy Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Renhe Pharmacy Co Ltd. The current obv is 795,512,545.

Renhe Pharmacy Co Ltd Daily On-Balance Volume (OBV) ChartRenhe Pharmacy Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Renhe Pharmacy Co Ltd. The current mfi is 54.79.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Renhe Pharmacy Co Ltd Daily Money Flow Index (MFI) ChartRenhe Pharmacy Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Renhe Pharmacy Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-03STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-06WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-08ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-09STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-11-15MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-11-20STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-21STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-23MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-27SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-29CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-30STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-01STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-04STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-05STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-07BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-12-14DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-18STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-19STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-26BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-27RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-28SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-10MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-01-29SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-30CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-31SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-06RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-19WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-02-26STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-29WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-12CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-20WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-27STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-28STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside

6.3. Candlestick Patterns

Renhe Pharmacy Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Renhe Pharmacy Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5055.299
Ma 20Greater thanMa 506.527
Ma 50Greater thanMa 1006.291
Ma 100Greater thanMa 2006.557
OpenGreater thanClose6.520
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Renhe Pharmacy Co Ltd with someone you think should read this too:
  • Are you bullish or bearish on Renhe Pharmacy Co Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Renhe Pharmacy Co Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Renhe Pharmacy Co Ltd

I send you an email if I find something interesting about Renhe Pharmacy Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Renhe Pharmacy Co Ltd.

Receive notifications about Renhe Pharmacy Co Ltd in your mailbox!